APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endothelial Keratoplasty (EK)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endothelial Keratoplasty (EK) Market Analysis and Forecast 2026-2032

12 August 2026178 pages

Choose your research edition.

Industry ResearchEndothelial Keratoplasty (EK) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endothelial Keratoplasty (EK) Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Endothelial Keratoplasty (EK) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endothelial Keratoplasty (EK) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Endothelial Keratoplasty (EK) Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global Endothelial Keratoplasty (EK) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Endothelial Keratoplasty (EK) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endothelial Keratoplasty (EK) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endothelial Keratoplasty (EK) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endothelial Keratoplasty (EK) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Endothelial Keratoplasty (EK) include Precise Bio, Altomed, CorneaGen, Mayo Clinic, Cellusion and LaserVision, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Endothelial Keratoplasty (EK), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endothelial Keratoplasty (EK), also provides the revenue of main regions and countries. Of the upcoming market potential for Endothelial Keratoplasty (EK), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endothelial Keratoplasty (EK) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endothelial Keratoplasty (EK) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Endothelial Keratoplasty (EK) revenue, projected growth trends, production technology, application and end-user industry.

Endothelial Keratoplasty (EK) Segment by Company

Precise Bio

Altomed

CorneaGen

Mayo Clinic

Cellusion

LaserVision

Endothelial Keratoplasty (EK) Segment by Type

Descemet's Stripping Endothelial Keratoplasty (DSEK)

Descemet's Membrane Endothelial Keratosplaty (DMEK)

Endothelial Keratoplasty (EK) Segment by Application

Adults

Children

Endothelial Keratoplasty (EK) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endothelial Keratoplasty (EK) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endothelial Keratoplasty (EK) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endothelial Keratoplasty (EK).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Endothelial Keratoplasty (EK) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Endothelial Keratoplasty (EK) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endothelial Keratoplasty (EK) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endothelial Keratoplasty (EK) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Descemet's Stripping Endothelial Keratoplasty (DSEK) Major Player Table 3. Descemet's Membrane Endothelial Keratosplaty (DMEK) Major Player Table 4. Global Endothelial Keratoplasty (EK) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adults Major Player Table 6. Children Major Player Table 7. Endothelial Keratoplasty (EK) Industry Trends Table 8. Endothelial Keratoplasty (EK) Industry Drivers Table 9. Endothelial Keratoplasty (EK) Industry Opportunities and Challenges Table 10. Endothelial Keratoplasty (EK) Industry Restraints Table 11. Global Endothelial Keratoplasty (EK) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Endothelial Keratoplasty (EK) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Endothelial Keratoplasty (EK) Market Share by Region (2021-2026) Table 14. Global Endothelial Keratoplasty (EK) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Endothelial Keratoplasty (EK) Market Share by Region (2027-2032) Table 16. Global Endothelial Keratoplasty (EK) Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Endothelial Keratoplasty (EK) Revenue Market Share by Players (2021-2026) Table 18. Global Endothelial Keratoplasty (EK) Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Endothelial Keratoplasty (EK) Key Players Headquarters & Area Served Table 20. Global Endothelial Keratoplasty (EK) Players, Product Type & Application Table 21. Global Endothelial Keratoplasty (EK) Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Endothelial Keratoplasty (EK) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Endothelial Keratoplasty (EK) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Endothelial Keratoplasty (EK) Revenue Market Share by Type (2021-2026) Table 28. Global Endothelial Keratoplasty (EK) Revenue Market Share by Type (2027-2032) Table 29. Global Endothelial Keratoplasty (EK) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Endothelial Keratoplasty (EK) Revenue Market Share by Application (2021-2026) Table 33. Global Endothelial Keratoplasty (EK) Revenue Market Share by Application (2027-2032) Table 34. Precise Bio Company Information Table 35. Precise Bio Business Overview Table 36. Precise Bio Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Precise Bio Endothelial Keratoplasty (EK) Product Portfolio Table 38. Precise Bio Recent Development Table 39. Altomed Company Information Table 40. Altomed Business Overview Table 41. Altomed Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Altomed Endothelial Keratoplasty (EK) Product Portfolio Table 43. Altomed Recent Development Table 44. CorneaGen Company Information Table 45. CorneaGen Business Overview Table 46. CorneaGen Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. CorneaGen Endothelial Keratoplasty (EK) Product Portfolio Table 48. CorneaGen Recent Development Table 49. Mayo Clinic Company Information Table 50. Mayo Clinic Business Overview Table 51. Mayo Clinic Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Mayo Clinic Endothelial Keratoplasty (EK) Product Portfolio Table 53. Mayo Clinic Recent Development Table 54. Cellusion Company Information Table 55. Cellusion Business Overview Table 56. Cellusion Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Cellusion Endothelial Keratoplasty (EK) Product Portfolio Table 58. Cellusion Recent Development Table 59. LaserVision Company Information Table 60. LaserVision Business Overview Table 61. LaserVision Endothelial Keratoplasty (EK) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. LaserVision Endothelial Keratoplasty (EK) Product Portfolio Table 63. LaserVision Recent Development Table 64. North America Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Endothelial Keratoplasty (EK) Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Endothelial Keratoplasty (EK) Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Endothelial Keratoplasty (EK) Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Endothelial Keratoplasty (EK) Revenue by Country (US$ Million) & (2027-2032) Table 78. China Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 79. China Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 80. China Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 81. China Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Endothelial Keratoplasty (EK) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Endothelial Keratoplasty (EK) Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Endothelial Keratoplasty (EK) Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Endothelial Keratoplasty (EK) Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Endothelial Keratoplasty (EK) Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Endothelial Keratoplasty (EK) Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Endothelial Keratoplasty (EK) Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Endothelial Keratoplasty (EK) Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Endothelial Keratoplasty (EK) Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Endothelial Keratoplasty (EK) Image Figure 2. Global Endothelial Keratoplasty (EK) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endothelial Keratoplasty (EK) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Descemet's Stripping Endothelial Keratoplasty (DSEK) Image Figure 5. Descemet's Membrane Endothelial Keratosplaty (DMEK) Image Figure 6. Global Endothelial Keratoplasty (EK) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Endothelial Keratoplasty (EK) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adults Image Figure 9. Children Image Figure 10. Global Endothelial Keratoplasty (EK) Market Size (US$ Million) & (2021-2032) Figure 11. Global Endothelial Keratoplasty (EK) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Endothelial Keratoplasty (EK) Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Endothelial Keratoplasty (EK) Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Endothelial Keratoplasty (EK) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Endothelial Keratoplasty (EK) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Endothelial Keratoplasty (EK) Revenue Market Share by Type (2021-2032) Figure 18. Global Endothelial Keratoplasty (EK) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Endothelial Keratoplasty (EK) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Endothelial Keratoplasty (EK) Revenue Market Share by Application (2021-2032) Figure 21. North America Endothelial Keratoplasty (EK) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032) Figure 23. North America Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032) Figure 24. North America Endothelial Keratoplasty (EK) Revenue Share by Country (2021-2032) Figure 25. United States Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Endothelial Keratoplasty (EK) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032) Figure 30. Europe Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032) Figure 31. Europe Endothelial Keratoplasty (EK) Revenue Share by Country (2021-2032) Figure 32. Germany Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Endothelial Keratoplasty (EK) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032) Figure 42. China Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032) Figure 43. Asia Endothelial Keratoplasty (EK) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032) Figure 45. Asia Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032) Figure 46. Asia Endothelial Keratoplasty (EK) Revenue Share by Region (2021-2032) Figure 47. Japan Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Endothelial Keratoplasty (EK) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032) Figure 55. SAMEA Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032) Figure 56. SAMEA Endothelial Keratoplasty (EK) Revenue Share by Country (2021-2032) Figure 57. Brazil Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Endothelial Keratoplasty (EK) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Descemet's Stripping Endothelial Keratoplasty (DSEK)
  • Descemet's Membrane Endothelial Keratosplaty (DMEK)
Applications
  • Adults
  • Children
Companies covered
  • Precise Bio
  • Altomed
  • CorneaGen
  • Mayo Clinic
  • Cellusion
  • LaserVision

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endothelial Keratoplasty (EK) Market by Type
  3. 1.2.1 Global Endothelial Keratoplasty (EK) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Descemet's Stripping Endothelial Keratoplasty (DSEK)
  5. 1.2.3 Descemet's Membrane Endothelial Keratosplaty (DMEK)
  6. 1.3 Endothelial Keratoplasty (EK) Market by Application
  7. 1.3.1 Global Endothelial Keratoplasty (EK) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adults
  9. 1.3.3 Children
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Endothelial Keratoplasty (EK) Market Dynamics
  1. 2.1 Endothelial Keratoplasty (EK) Industry Trends
  2. 2.2 Endothelial Keratoplasty (EK) Industry Drivers
  3. 2.3 Endothelial Keratoplasty (EK) Industry Opportunities and Challenges
  4. 2.4 Endothelial Keratoplasty (EK) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Endothelial Keratoplasty (EK) Market Perspective (2021-2032)
  2. 3.2 Global Endothelial Keratoplasty (EK) Growth Trends by Region
  3. 3.2.1 Global Endothelial Keratoplasty (EK) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endothelial Keratoplasty (EK) Market Size by Region (2021-2026)
  5. 3.2.3 Global Endothelial Keratoplasty (EK) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Endothelial Keratoplasty (EK) Revenue by Players
  2. 4.1.1 Global Endothelial Keratoplasty (EK) Revenue by Players (2021-2026)
  3. 4.1.2 Global Endothelial Keratoplasty (EK) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Endothelial Keratoplasty (EK) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endothelial Keratoplasty (EK) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Endothelial Keratoplasty (EK) Key Players Headquarters & Area Served
  7. 4.4 Global Endothelial Keratoplasty (EK) Players, Product Type & Application
  8. 4.5 Global Endothelial Keratoplasty (EK) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Endothelial Keratoplasty (EK) Market CR5 and HHI
  11. 4.6.3 2025 Endothelial Keratoplasty (EK) Tier 1, Tier 2, and Tier 3
5 Endothelial Keratoplasty (EK) Market Size by Type
  1. 5.1 Global Endothelial Keratoplasty (EK) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 5.3 Global Endothelial Keratoplasty (EK) Revenue Market Share by Type (2021-2032)
6 Endothelial Keratoplasty (EK) Market Size by Application
  1. 6.1 Global Endothelial Keratoplasty (EK) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  3. 6.3 Global Endothelial Keratoplasty (EK) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Precise Bio
  2. 7.1.1 Precise Bio Company Information
  3. 7.1.2 Precise Bio Business Overview
  4. 7.1.3 Precise Bio Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Precise Bio Endothelial Keratoplasty (EK) Product Portfolio
  6. 7.1.5 Precise Bio Recent Developments
  7. 7.2 Altomed
  8. 7.2.1 Altomed Company Information
  9. 7.2.2 Altomed Business Overview
  10. 7.2.3 Altomed Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Altomed Endothelial Keratoplasty (EK) Product Portfolio
  12. 7.2.5 Altomed Recent Developments
  13. 7.3 CorneaGen
  14. 7.3.1 CorneaGen Company Information
  15. 7.3.2 CorneaGen Business Overview
  16. 7.3.3 CorneaGen Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CorneaGen Endothelial Keratoplasty (EK) Product Portfolio
  18. 7.3.5 CorneaGen Recent Developments
  19. 7.4 Mayo Clinic
  20. 7.4.1 Mayo Clinic Company Information
  21. 7.4.2 Mayo Clinic Business Overview
  22. 7.4.3 Mayo Clinic Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mayo Clinic Endothelial Keratoplasty (EK) Product Portfolio
  24. 7.4.5 Mayo Clinic Recent Developments
  25. 7.5 Cellusion
  26. 7.5.1 Cellusion Company Information
  27. 7.5.2 Cellusion Business Overview
  28. 7.5.3 Cellusion Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cellusion Endothelial Keratoplasty (EK) Product Portfolio
  30. 7.5.5 Cellusion Recent Developments
  31. 7.6 LaserVision
  32. 7.6.1 LaserVision Company Information
  33. 7.6.2 LaserVision Business Overview
  34. 7.6.3 LaserVision Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LaserVision Endothelial Keratoplasty (EK) Product Portfolio
  36. 7.6.5 LaserVision Recent Developments
8 North America
  1. 8.1 North America Endothelial Keratoplasty (EK) Revenue (2021-2032)
  2. 8.2 North America Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 8.2.1 North America Endothelial Keratoplasty (EK) Revenue by Type (2021-2026)
  4. 8.2.2 North America Endothelial Keratoplasty (EK) Revenue by Type (2027-2032)
  5. 8.3 North America Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032)
  6. 8.4 North America Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  7. 8.4.1 North America Endothelial Keratoplasty (EK) Revenue by Application (2021-2026)
  8. 8.4.2 North America Endothelial Keratoplasty (EK) Revenue by Application (2027-2032)
  9. 8.5 North America Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032)
  10. 8.6 North America Endothelial Keratoplasty (EK) Revenue by Country
  11. 8.6.1 North America Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Endothelial Keratoplasty (EK) Revenue by Country (2021-2026)
  13. 8.6.3 North America Endothelial Keratoplasty (EK) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Endothelial Keratoplasty (EK) Revenue (2021-2032)
  2. 9.2 Europe Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Endothelial Keratoplasty (EK) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Endothelial Keratoplasty (EK) Revenue by Type (2027-2032)
  5. 9.3 Europe Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Endothelial Keratoplasty (EK) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Endothelial Keratoplasty (EK) Revenue by Application (2027-2032)
  9. 9.5 Europe Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Endothelial Keratoplasty (EK) Revenue by Country
  11. 9.6.1 Europe Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Endothelial Keratoplasty (EK) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Endothelial Keratoplasty (EK) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Endothelial Keratoplasty (EK) Revenue (2021-2032)
  2. 10.2 China Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 10.2.1 China Endothelial Keratoplasty (EK) Revenue by Type (2021-2026)
  4. 10.2.2 China Endothelial Keratoplasty (EK) Revenue by Type (2027-2032)
  5. 10.3 China Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032)
  6. 10.4 China Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  7. 10.4.1 China Endothelial Keratoplasty (EK) Revenue by Application (2021-2026)
  8. 10.4.2 China Endothelial Keratoplasty (EK) Revenue by Application (2027-2032)
  9. 10.5 China Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endothelial Keratoplasty (EK) Revenue (2021-2032)
  2. 11.2 Asia Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Endothelial Keratoplasty (EK) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Endothelial Keratoplasty (EK) Revenue by Type (2027-2032)
  5. 11.3 Asia Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Endothelial Keratoplasty (EK) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Endothelial Keratoplasty (EK) Revenue by Application (2027-2032)
  9. 11.5 Asia Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Endothelial Keratoplasty (EK) Revenue by Country
  11. 11.6.1 Asia Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Endothelial Keratoplasty (EK) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Endothelial Keratoplasty (EK) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endothelial Keratoplasty (EK) Revenue (2021-2032)
  2. 12.2 SAMEA Endothelial Keratoplasty (EK) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Endothelial Keratoplasty (EK) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Endothelial Keratoplasty (EK) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Endothelial Keratoplasty (EK) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Endothelial Keratoplasty (EK) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Endothelial Keratoplasty (EK) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Endothelial Keratoplasty (EK) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Endothelial Keratoplasty (EK) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Endothelial Keratoplasty (EK) Revenue by Country
  11. 12.6.1 SAMEA Endothelial Keratoplasty (EK) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Endothelial Keratoplasty (EK) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Endothelial Keratoplasty (EK) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst